Finally, we demonstrate that miR-138 enhances osteosarcoma cell chemosensitivity to cisplatin by targeting EZH2. In conclusion, our data suggest the important role of miR-138 in the osteosarcoma process and indicate its potential application in osteosarcoma therapy. The gene discussed is EZH2; the disease is osteosarcoma.